Arcadia Biosciences Posts Positive EPS and Revenue Figures in Q3 Update
Thursday, 28 March 2024, 20:11
Arcadia Biosciences Q3 Earnings Update
Arcadia Biosciences reported its third-quarter financial results, revealing a mixed picture for investors and analysts.
Key Highlights:
- GAAP EPS: The company posted a surprising EPS of -$2.10, surpassing expectations by $0.48.
- Revenue: However, the revenue figure of $1.17M missed estimates by $0.58M.
Despite the revenue shortfall, the better-than-expected earnings per share signal potential resilience and positive performance for Arcadia Biosciences in the current market conditions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.